191 related articles for article (PubMed ID: 21275429)
1. Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization.
Zhang Z; Wriggers W
Biochemistry; 2011 Mar; 50(12):2144-56. PubMed ID: 21275429
[TBL] [Abstract][Full Text] [Related]
2. Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor.
Odaka M; Kohda D; Lax I; Schlessinger J; Inagaki F
J Biochem; 1997 Jul; 122(1):116-21. PubMed ID: 9276679
[TBL] [Abstract][Full Text] [Related]
3. Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation.
Zhou M; Felder S; Rubinstein M; Hurwitz DR; Ullrich A; Lax I; Schlessinger J
Biochemistry; 1993 Aug; 32(32):8193-8. PubMed ID: 8347619
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants of epidermal growth factor binding: a molecular dynamics study.
Sanders JM; Wampole ME; Thakur ML; Wickstrom E
PLoS One; 2013; 8(1):e54136. PubMed ID: 23382875
[TBL] [Abstract][Full Text] [Related]
5. In-cell structural dynamics of an EGF receptor during ligand-induced dimer-oligomer transition.
Kozer N; Clayton AHA
Eur Biophys J; 2020 Jan; 49(1):21-37. PubMed ID: 31740999
[TBL] [Abstract][Full Text] [Related]
6. Binding of single-mutant epidermal growth factor (EGF) ligands alters the stability of the EGF receptor dimer and promotes growth signaling.
Pascarelli S; Merzhakupova D; Uechi GI; Laurino P
J Biol Chem; 2021 Jul; 297(1):100872. PubMed ID: 34126069
[TBL] [Abstract][Full Text] [Related]
7. Two EGF molecules contribute additively to stabilization of the EGFR dimer.
Lemmon MA; Bu Z; Ladbury JE; Zhou M; Pinchasi D; Lax I; Engelman DM; Schlessinger J
EMBO J; 1997 Jan; 16(2):281-94. PubMed ID: 9029149
[TBL] [Abstract][Full Text] [Related]
8. Activation of the epidermal growth factor receptor: a series of twists and turns.
Poger D; Mark AE
Biochemistry; 2014 Apr; 53(16):2710-21. PubMed ID: 24697572
[TBL] [Abstract][Full Text] [Related]
9. Role of N-glycosylation in EGFR ectodomain ligand binding.
Azimzadeh Irani M; Kannan S; Verma C
Proteins; 2017 Aug; 85(8):1529-1549. PubMed ID: 28486782
[TBL] [Abstract][Full Text] [Related]
10. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.
Ferguson KM; Berger MB; Mendrola JM; Cho HS; Leahy DJ; Lemmon MA
Mol Cell; 2003 Feb; 11(2):507-17. PubMed ID: 12620237
[TBL] [Abstract][Full Text] [Related]
11. Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation.
Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2014 Sep; 289(38):26178-26188. PubMed ID: 25086039
[TBL] [Abstract][Full Text] [Related]
12. Anti-EGFR antibody 528 binds to domain III of EGFR at a site shifted from the cetuximab epitope.
Makabe K; Yokoyama T; Uehara S; Uchikubo-Kamo T; Shirouzu M; Kimura K; Tsumoto K; Asano R; Tanaka Y; Kumagai I
Sci Rep; 2021 Mar; 11(1):5790. PubMed ID: 33707468
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha.
Garrett TP; McKern NM; Lou M; Elleman TC; Adams TE; Lovrecz GO; Zhu HJ; Walker F; Frenkel MJ; Hoyne PA; Jorissen RN; Nice EC; Burgess AW; Ward CW
Cell; 2002 Sep; 110(6):763-73. PubMed ID: 12297049
[TBL] [Abstract][Full Text] [Related]
14. Conformational stability of the epidermal growth factor (EGF) receptor as influenced by glycosylation, dimerization and EGF hormone binding.
Taylor ES; Pol-Fachin L; Lins RD; Lower SK
Proteins; 2017 Apr; 85(4):561-570. PubMed ID: 28019699
[TBL] [Abstract][Full Text] [Related]
15. A 40-kDa epidermal growth factor/transforming growth factor alpha-binding domain produced by limited proteolysis of the extracellular domain of the epidermal growth factor receptor.
Kohda D; Odaka M; Lax I; Kawasaki H; Suzuki K; Ullrich A; Schlessinger J; Inagaki F
J Biol Chem; 1993 Jan; 268(3):1976-81. PubMed ID: 8420971
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S
Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3.
Jura N; Shan Y; Cao X; Shaw DE; Kuriyan J
Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21608-13. PubMed ID: 20007378
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for negative cooperativity in growth factor binding to an EGF receptor.
Alvarado D; Klein DE; Lemmon MA
Cell; 2010 Aug; 142(4):568-79. PubMed ID: 20723758
[TBL] [Abstract][Full Text] [Related]
19. EGFR oligomerization organizes kinase-active dimers into competent signalling platforms.
Needham SR; Roberts SK; Arkhipov A; Mysore VP; Tynan CJ; Zanetti-Domingues LC; Kim ET; Losasso V; Korovesis D; Hirsch M; Rolfe DJ; Clarke DT; Winn MD; Lajevardipour A; Clayton AH; Pike LJ; Perani M; Parker PJ; Shan Y; Shaw DE; Martin-Fernandez ML
Nat Commun; 2016 Oct; 7():13307. PubMed ID: 27796308
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor (EGF) induces oligomerization of soluble, extracellular, ligand-binding domain of EGF receptor. A low resolution projection structure of the ligand-binding domain.
Lax I; Mitra AK; Ravera C; Hurwitz DR; Rubinstein M; Ullrich A; Stroud RM; Schlessinger J
J Biol Chem; 1991 Jul; 266(21):13828-33. PubMed ID: 1856216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
